The Latest

NECC and the Future of Compounding Pharmacy
NECC and the Future of Compounding PharmacyCompounding pharmacist's case hinged on whether he was "willfully indifferent."
Pharmacists and Patients Worry About Naloxone Dispensing
Pharmacists and Patients Worry About Naloxone DispensingNaloxone is available, but is it actually being used?
CE: Diabetes: Setting the stride to improve glycemic control
CE: Diabetes: Setting the stride to improve glycemic control
When Going the Extra Mile isn’t Enough
When Going the Extra Mile isn’t EnoughWhat do you do about the customer who is never satisfied?
Addiction Risks Rise after Day Three of an Opioid PrescriptionThe length of an initial opioid prescription influences the risks of long-term use.
Reducing Taxes and Regulations Trumps Price Controls
Reducing Taxes and Regulations Trumps Price ControlsTrump's strategy to lower Rx drug spending.
Prescribing Rights: Worth it?
Prescribing Rights: Worth it?Pharmacists are now recognized as providers nearly everywhere—here’s a look at what this could mean for you.
Fighting Opioid Abuse
Fighting Opioid AbuseHow pharmacists can help fight the battle.
FDA Approves Rucaparib for Advanced Ovarian Cancer
FDA Approves Rucaparib for Advanced Ovarian CancerThe New Drug Review for April
Anakinra for RA and Refractory Idiopathic Recurrent Pericarditis
Anakinra for RA and Refractory Idiopathic Recurrent PericarditisCardiac Matters—What you need to know about anakinra